OBJECTIVE: To understand participants' experiences and understandings of the interventions in the trial of a computerised decision support tool in patients with atrial fibrillation being considered for anti-coagulation treatment. DESIGN: Qualitative process evaluation carried out alongside the trial: non-participant observation and semistructured interviews. PARTICIPANTS: 30 participants aged >60 years taking part in the trial of a computerised decision support tool. RESULTS: Qualitative evidence provided the rationale to undertake a decision to discontinue one arm of the trial on the basis that the intervention in that arm, a standard gamble values elicitation exercise was causing confusion and was unlikely to produce valid data on participant values. CONCLUSIONS: Qualitative methods used alongside a trial allow an understanding of the process and progress of a trial, and provide evidence to intervene in the trial if necessary, including evidence for the rationale to discontinue an intervention arm of the trial.
RCT Entities:
OBJECTIVE: To understand participants' experiences and understandings of the interventions in the trial of a computerised decision support tool in patients with atrial fibrillation being considered for anti-coagulation treatment. DESIGN: Qualitative process evaluation carried out alongside the trial: non-participant observation and semistructured interviews. PARTICIPANTS: 30 participants aged >60 years taking part in the trial of a computerised decision support tool. RESULTS: Qualitative evidence provided the rationale to undertake a decision to discontinue one arm of the trial on the basis that the intervention in that arm, a standard gamble values elicitation exercise was causing confusion and was unlikely to produce valid data on participant values. CONCLUSIONS: Qualitative methods used alongside a trial allow an understanding of the process and progress of a trial, and provide evidence to intervene in the trial if necessary, including evidence for the rationale to discontinue an intervention arm of the trial.
Authors: A Welton; J Hepworth; N Collins; D Ford; C Knott; S Meredith; A Walgrove; H Wilkes; M Vickers Journal: Climacteric Date: 2004-03 Impact factor: 3.005
Authors: Richard G Thomson; Martin P Eccles; I Nick Steen; Jane Greenaway; Lynne Stobbart; Madeleine J Murtagh; Carl R May Journal: Qual Saf Health Care Date: 2007-06
Authors: Mark H Eckman; Ruth E Wise; Katherine Naylor; Lora Arduser; Gregory Y H Lip; Brett Kissela; Matthew Flaherty; Dawn Kleindorfer; Faisal Khan; Daniel P Schauer; John Kues; Alexandru Costea Journal: Curr Med Res Opin Date: 2015-03-13 Impact factor: 2.580
Authors: Sian K Smith; Paul Kearney; Lyndal Trevena; Alexandra Barratt; Don Nutbeam; Kirsten J McCaffery Journal: Health Expect Date: 2012-04-19 Impact factor: 3.377
Authors: Henry N Young; S Nadra Havican; Sara Griesbach; Joshua M Thorpe; Betty A Chewning; Christine A Sorkness Journal: Telemed J E Health Date: 2012-06-01 Impact factor: 3.536
Authors: Leslie A Curry; Harlan M Krumholz; Alicia O'Cathain; Vicki L Plano Clark; Emily Cherlin; Elizabeth H Bradley Journal: Circ Cardiovasc Qual Outcomes Date: 2013-01-01
Authors: Lisa Ann Conboy; Eric Macklin; John Kelley; Efi Kokkotou; Anthony Lembo; Ted Kaptchuk Journal: Soc Sci Med Date: 2009-11-10 Impact factor: 4.634
Authors: Richard G Thomson; Martin P Eccles; I Nick Steen; Jane Greenaway; Lynne Stobbart; Madeleine J Murtagh; Carl R May Journal: Qual Saf Health Care Date: 2007-06